Nanexa Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 123.6%.

Top 25 shareholders own 50.85% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.9%	Novo Nordisk A/S	27,000,000	€3.7m	0%	no data
5.44%	Avanza Fonder AB	7,378,659	€999.0k	0%	0.01%
5.16%	Applied Ventures, LLC	7,004,226	€948.3k	0%	18.47%
3.36%	Nolsterby Invest AB, Asset Management Arm	4,561,606	€617.6k	0%	53.23%
3.07%	M2 Capital Management AB	4,167,194	€564.2k	0%	0.27%
2.61%	Jan Petersen	3,537,863	€479.0k	0%	no data
2.53%	Nordnet AB (publ), Asset Management Arm	3,429,219	€464.3k	0%	0.06%
2.42%	Mikael Jacobsson	3,279,665	€444.0k	0%	no data
2.14%	Formue Nord A/S	2,909,103	€393.9k	0%	23.54%
1.72%	Jan Nordqvist	2,327,825	€315.2k	0%	no data
0.77%	Goran Ando	1,040,000	€140.8k	0%	no data
0.33%	Marten Rooth	442,000	€59.8k	0%	no data
0.3%	Anders Johansson	410,250	€55.5k	0%	no data
0.27%	David Westberg	371,178	€50.3k	0%	no data
0.19%	Magnus Westgren	254,164	€34.4k	0%	no data
0.18%	Jakob Hansen	250,000	€33.8k	0%	no data
0.13%	Eva Nilsagard	180,000	€24.4k	0%	no data
0.11%	Björn Svanström	150,000	€20.3k	0%	no data
0.081%	Otto Skolling	109,600	€14.8k	0%	no data
0.044%	Birgit Norinder	60,000	€8.1k	0%	no data
0.038%	Bengt Gustavsson	52,000	€7.0k	0%	no data
0.033%	Kristine Bäck	45,000	€6.1k	0%	no data
0.015%	Sven Undeland	20,000	€2.7k	0%	no data
0.013%	FCG Fonder AB	17,262	€2.3k	0%	no data
0.0052%	Joel Hellrup	7,000	€948.0	0%	no data